Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 273

The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.

Machine learning for antimicrobial peptide identification and design

Open access
Wan, Fangping, Wong, Felix, Collins, James J., de la Fuente-Nunez, Cesar·2024·Nature Reviews Bioengineering

Abstract

Artificial intelligence (AI) and machine learning (ML) models are being deployed in many domains of society and have recently reached the field of drug discovery. Given the increasing prevalence of antimicrobial resistance, as well as the challenges intrinsic to antibiotic development, there is an urgent need to accelerate the design of new antimicrobial therapies. Antimicrobial peptides (AMPs) are therapeutic agents for treating bacterial infections, but their translation into the clinic has been slow owing to toxicity, poor stability, limited cellular penetration and high cost, among other issues. Recent advances in AI and ML have led to breakthroughs in our abilities to predict biomolecular properties and structures and to generate new molecules. The ML-based modelling of peptides may overcome some of the disadvantages associated with traditional drug discovery and aid the rapid development and translation of AMPs. Here, we provide an introduction to this emerging field and survey ML approaches that can be used to address issues currently hindering AMP development. We also outline important limitations that can be addressed for the broader adoption of AMPs in clinical practice, as well as new opportunities in data-driven peptide design. Artificial intelligence (AI) and machine learning (ML) are reshaping antibiotic discovery. In this Review, ML approaches that have been and can be used to address issues hindering antimicrobial peptide identification and development are surveyed. Machine learning (ML) can aid antimicrobial peptide (AMP) design and discovery. It can be applied to improve drug efficacy, predict medicinal chemistry and reduce the overall time and cost of drug development. ML can be used for the prediction of therapeutic properties — such as antimicrobial efficacy, and absorption, distribution, metabolism, excretion and toxicity (ADMET) — and macromolecular structures. Deep generative models are promising approaches to designing new AMPs. Important limitations in AMP development include lack of selectivity, undesirable physicochemical and medicinal chemistry properties, unspecific or unknown mechanisms of action, high cost of peptide synthesis, and generation of industrial waste. ML can help to overcome these limitations by applying relevant models trained on high-quality datasets. Machine learning (ML) can aid antimicrobial peptide (AMP) design and discovery. It can be applied to improve drug efficacy, predict medicinal chemistry and reduce the overall time and cost of drug development. ML can be used for the prediction of therapeutic properties — such as antimicrobial efficacy, and absorption, distribution, metabolism, excretion and toxicity (ADMET) — and macromolecular structures. Deep generative models are promising approaches to designing new AMPs. Important limitations in AMP development include lack of selectivity, undesirable physicochemical and medicinal chemistry properties, unspecific or unknown mechanisms of action, high cost of peptide synthesis, and generation of industrial waste. ML can help to overcome these limitations by applying relevant models trained on high-quality datasets.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s44222-024-00152-x

Cites

188 of 188 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 188 references

Cited by

See all 273

Metadata

Authors
Wan, F., Wong, F., Collins, J. J., & de la Fuente-Nunez, C.
Venue
Nature Reviews Bioengineering
Published
2024-02-26
Volume
2
Issue
5
Pages
392-407
ISSN
2731-6092 (ISSN-L)
OpenAlex
W4392162030
Cited by
273
References
188
FWCI
20.61
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Machine learning for antimicrobial peptide identification and design. https://app.cochat.ai/papers/10.1038/s44222-024-00152-x
The paper
Wan, F., Wong, F., Collins, J. J., & de la Fuente-Nunez, C. (2024). Machine learning for antimicrobial peptide identification and design. Nature Reviews Bioengineering. https://doi.org/10.1038/s44222-024-00152-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.